JP Patent

JP6716785B2 — Ｈｉｖウイルス感染症の予防的または治療的処置に有用な治療用化合物

Assigned to ギリアード サイエンシーズ， インコーポレイテッド · Expires 2020-07-01 · 6y expired

What this patent protects

Patent listed against lenacapavir-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
JP6716785B2
Jurisdiction
JP
Classification
—
Expires
2020-07-01
Drug substance claim
No
Drug product claim
No
Assignee
ギリアード サイエンシーズ， インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.